Team uncovers a potential therapeutic approach for patients deficient in a protein called Shank3.

Read how NIBR and Dana-Farber scientists aim to expand immunotherapy options for patients

Novartis researchers are peering deep inside knees to see if regenerated cartilage is springy like natural cartilage.

Novartis researchers aim to improve the lives of patients with osteoarthritis.

Novartis is taming nuclear power and putting it to use to treat advanced cancer.

Genome editing advances drug discovery in biomedical research.

Novartis is investing in a novel type of medicine to reduce the risk of heart disease.

John Hadcock’s wife Laura gave him an ultimatum: Run the energy out of Sunny, the new puppy, or take her back to the breeder. So Hadcock started running. On his first trip out, he had to stop half a mile in.

Umbilical cords are a potentially life-saving source of blood stem cells for people with leukemia and other diseases. But there aren’t enough cells to meet demand. Now an experimental treatment offers hope for a solution.

The molecule restores the activity of neurons and neural circuits in a model of the disease.